|
|
Article: Amgen Recommends Rejection of Mini-Tender Offer by TRC Capital Corporation.
- Article from:
- Business Wire
- Article date:
- May 18, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
THOUSAND OAKS, Calif. -- Amgen (NASDAQ:AMGN) has been notified of an unsolicited "mini-tender offer" by TRC Capital Corporation (TRC) to purchase up to 1,500,000 shares of its common stock, representing less than 0.13 percent of Amgen's outstanding shares, at a price of $53.75 per share.
Amgen does not endorse TRC's unsolicited mini-tender offer and recommends that stockholders not tender their shares in response to this mini-tender offer. Amgen wants all stockholders, broker-deals and other market participants to be clear that Amgen is not associated in any way with TRC, this mini-tender offer or the offer documentation.
Amgen understands that TRC has ...